flash-tech

FDA approves Telix brain cancer imaging drug Pixclara

The Trump administration’s push to bring US drug spending down is a powerful incentive for pharmaceutical companies to boost prices and reduce access elsewhere in the world, a study found.

AI executives' calls to slow development of the technology are likely to weigh on chipmaker and supply-chain stocks in the near term. Bloomberg's Sunny Bangia and Anthony Stephens break down the news. (Source: Bloomberg)

Bandai finds right recipe to turn toothbrushes into Gundam models

Fujitsu to export AI chips built on supercomputer tech to US, Asia

Applied Materials using AI to speed chip materials discovery, Japan chief says

Key deals this week: META, ADI, BSP, AAPL, and more

President denounces demands for regulation as existential fears over technology move to the centre of US politics

Fujitsu to export AI chips built on supercomputer tech to US, Asia

Key deals this week: META, ADI, BSP, AAPL, and more